National Health Investors (NYSE:NHI – Get Rating) is set to announce its earnings results after the market closes on Monday, August 8th. Analysts expect the company to announce earnings of $1.21 per share for the quarter. National Health Investors has set its FY 2022 guidance at $4.32-$4.42 EPS.Individual that are interested in registering for the company’s earnings conference call can do so using this link.
National Health Investors (NYSE:NHI – Get Rating) last issued its quarterly earnings results on Monday, May 9th. The real estate investment trust reported $0.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.63 by ($0.45). The business had revenue of $71.33 million during the quarter, compared to analyst estimates of $73.06 million. National Health Investors had a net margin of 29.35% and a return on equity of 5.55%. The company’s revenue for the quarter was down 11.8% compared to the same quarter last year. During the same period in the prior year, the business posted $1.24 earnings per share. On average, analysts expect National Health Investors to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.
National Health Investors Trading Up 1.3 %
Ad Investing Trends
Russia Ignites West’s Battle for Energy Independence
Putin’s invasion of Ukraine has revealed the West’s dependence on Russia for their energy needs. Western countries are now scrambling for stable, renewable energy. World leaders must find new sources of minerals, such as copper, essential to their transition to energy independence.
Shares of NYSE:NHI opened at $64.84 on Monday. The company has a market cap of $2.97 billion, a P/E ratio of 35.24 and a beta of 0.88. The stock’s 50-day moving average is $60.46 and its 200-day moving average is $57.49. National Health Investors has a 52-week low of $50.22 and a 52-week high of $69.22. The company has a debt-to-equity ratio of 0.84, a quick ratio of 23.40 and a current ratio of 23.40.
National Health Investors Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, August 5th. Investors of record on Thursday, June 30th will be given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 5.55%. The ex-dividend date is Wednesday, June 29th. National Health Investors’s dividend payout ratio (DPR) is presently 195.65%.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in NHI. First Republic Investment Management Inc. bought a new position in National Health Investors during the first quarter worth about $204,000. Toroso Investments LLC bought a new position in shares of National Health Investors in the first quarter valued at approximately $215,000. PNC Financial Services Group Inc. raised its stake in shares of National Health Investors by 29.2% in the first quarter. PNC Financial Services Group Inc. now owns 5,092 shares of the real estate investment trust’s stock valued at $300,000 after acquiring an additional 1,150 shares during the last quarter. Penserra Capital Management LLC raised its stake in shares of National Health Investors by 28.9% in the first quarter. Penserra Capital Management LLC now owns 5,293 shares of the real estate investment trust’s stock valued at $312,000 after acquiring an additional 1,188 shares during the last quarter. Finally, Raymond James Financial Services Advisors Inc. raised its stake in shares of National Health Investors by 5.7% in the first quarter. Raymond James Financial Services Advisors Inc. now owns 6,806 shares of the real estate investment trust’s stock valued at $402,000 after acquiring an additional 368 shares during the last quarter. Institutional investors own 63.53% of the company’s stock.
Wall Street Analyst Weigh In
NHI has been the topic of a number of recent research reports. BMO Capital Markets downgraded National Health Investors from an “outperform” rating to a “market perform” rating and set a $62.00 target price on the stock. in a research report on Tuesday, June 21st. Credit Suisse Group initiated coverage on National Health Investors in a research report on Wednesday, June 22nd. They set an “underperform” rating on the stock. Finally, Capital One Financial initiated coverage on shares of National Health Investors in a research note on Friday, June 3rd. They set an “overweight” rating and a $64.00 price target for the company. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $60.25.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Should you invest $1,000 in National Health Investors right now?
Before you consider National Health Investors, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and National Health Investors wasn’t on the list.
While National Health Investors currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
Source: marketbeat.com
